BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26945895)

  • 1. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
    Asadi F; Razmi A; Dehpour AR; Shafiei M
    J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
    Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
    Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hypertrophic and anti-apoptotic effects of short peptides of potato protein hydrolysate against hyperglycemic condition in cardiomyoblast cells.
    Marthandam Asokan S; Yang JY; Lin WT
    Biomed Pharmacother; 2018 Nov; 107():1667-1673. PubMed ID: 30257384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
    Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
    Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy.
    Barzegar-Fallah A; Alimoradi H; Razmi A; Dehpour AR; Asgari M; Shafiei M
    Eur J Pharmacol; 2015 Nov; 767():152-9. PubMed ID: 26481166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
    Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.
    Cheng KC; Li Y; Chang WT; Chen ZC; Cheng JT; Tsai CC
    J Food Drug Anal; 2019 Jan; 27(1):355-364. PubMed ID: 30648591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
    Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
    Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells.
    Merten KE; Jiang Y; Kang YJ
    Exp Biol Med (Maywood); 2007 May; 232(5):682-9. PubMed ID: 17463165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.